Literature DB >> 15337040

A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter.

Norihiko Ikeda1, Junichi Maeda, Koichi Yashima, Masahiro Tsuboi, Harubumi Kato, Soichi Akada, Shinya Okada.   

Abstract

BACKGROUND: The biological behavior of small adenocarcinoma is different in each patient and these are especially enormous differences when evaluating solid tumors and nonsolid tumors.
METHODS: A total of 159 adenocarcinomas 2 cm or less in diameter were studied. Several clinicopathological factors were retrospectively analyzed.
RESULTS: The diameter of the primary tumors was less than 1 cm in 47 patients, 1-1.5 cm in 49 patients, and 1.5-2 cm in 63 patients, respectively. Almost all patients (147) were pathologic N0 and there were 12 node-positive patients (7.5%). Lymph-node involvement was observed in 1 patient with a tumor diameter measuring less than 1 cm and in 11 patients with a tumor diameter measuring 1-2 cm. According to Noguchi' s classification, 33 patients belonged to class A or B, 71 patients belonged to class C, and 55 patients belonged to class D, E, or F. The ratio of ground-glass opacity (GGO) area in the main tumor in high resolution computed tomography was classified into two groups with a threshold of 50%. There were 44 patients with a GGO ratio of equal to or greater than 50%, none of which indicated lymph-node metastasis or tumor recurrence during follow-up (5-year survival = 100%). On the contrary among 115 patients with a GGO ratio less than 50%, lymph-node involvement was indicated in 12 patients (10.4%) and the 5-year survival rate was 83.9%.
CONCLUSIONS: The biological malignancy of small adenocarcinomas might be accurately evaluated by the proportion of GGO area as well as the Noguchi classification.

Entities:  

Mesh:

Year:  2004        PMID: 15337040     DOI: 10.1016/j.athoracsur.2004.03.048

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

Review 1.  Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2013-10

Review 2.  Lung cancer staging: an overview of the new staging system and implications for radiographic clinical staging.

Authors:  Joshua Carson; David J Finley
Journal:  Semin Roentgenol       Date:  2011-07       Impact factor: 0.800

Review 3.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

Review 4.  Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment.

Authors:  Takayuki Fukui; Tetsuya Mitsudomi
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

5.  Important contributions to cardiothoracic surgery by Japanese thoracic and cardiac surgeons.

Authors:  Arthur E Baue
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-04

6.  A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Authors:  Chun-Lei Shi; Xue-Yan Zhang; Bao-Hui Han; Wei-Zhong He; Jie Shen; Tian-Qing Chu
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

Review 7.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Outcome of limited resection for lung cancer.

Authors:  Jeong Su Cho; Sanghoon Jheon; Sung Joon Park; Sook-Whan Sung; Choon Taek Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-02-12

9.  Prognostic factors for stage I lung adenocarcinoma and surgical management of subsolid nodules.

Authors:  Gökhan Kocaman; Mustafa Bülent Yenigün; Atilla Halil Elhan; Serpil Dizbay Sak; Elvin Hamzayev; Serkan Enön; Ayten Kayı Cangır; Cabir Yüksel
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

10.  Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer.

Authors:  Takeshi Hanagiri; Kenji Sugio; Hidetaka Uramoto; Tetsuya So; Yoshinobu Ichiki; Masakazu Sugaya; Kenji Ono; Manabu Yasuda; Tadahiro Nozoe; Kosei Yasumoto
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.